About Us
Meet the people behind Variant Bio
Our team's expertise spans genetics, molecular biology, therapeutics, anthropology, and ethics. We are united in the belief that human genomics has the power to transform drug development.
Andrew Farnum
Chief Executive Officer
Holly Vance
Chief Operating Officer
Stephane Castel, PhD
Co-Founder, Chief Technology Officer & Chief Genomics Officer
David Moller, MD
Chief Scientific Officer
Steve Bryant, PhD
Chief Business Officer
Laura Yerges-Armstrong, PhD
Sr. VP, Computational Genetics
Leslie Hepner
VP, Operations
Prathap Kasina
VP, Partnerships & Business Development
Stacey Drabic
VP, Biology
Yvette Latchman, PhD
Sr. Director, Discovery Research
Our Investors
